(Q37460808)

20 August 2017

Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial (English)

1 reference

multicenter clinical trial

20 August 2017

0 references

1 reference

6

Paul Emery

0 references

Frank van den Hoogen

12

object named as

Frank van den Hoogen

0 references

Ariane I. Herrick

object named as

Ariane Herrick

13

0 references

author name string

Peter A Merkel

1

1 reference

20 August 2017

Nancy P Silliman

2

1 reference

20 August 2017

Christopher P Denton

3

1 reference

20 August 2017

Daniel E Furst

4

1 reference

20 August 2017

Dinesh Khanna

5

1 reference

20 August 2017

Vivien M Hsu

7

1 reference

20 August 2017

James B Streisand

8

1 reference

20 August 2017

Richard P Polisson

9

1 reference

20 August 2017

Anita Akesson

10

1 reference

20 August 2017

John Coppock

11

1 reference

20 August 2017

Frank van den Hoogen

12

1 reference

20 August 2017

Maureen D Mayes

14

1 reference

20 August 2017

Douglas Veale

15

1 reference

20 August 2017

James R Seibold

16

1 reference

20 August 2017

Carol M Black

17

1 reference

20 August 2017

Joseph H Korn

18

1 reference

20 August 2017

CAT-192 Research Group

19

1 reference

20 August 2017

Scleroderma Clinical Trials Consortium

20

1 reference

20 August 2017

1 May 2008

1 reference

20 August 2017

Arthritis & Rheumatology

1 reference

20 August 2017

59

1 reference

20 August 2017

5

1 reference

20 August 2017

699-705

1 reference

Myofibroblasts and hyalinized collagen as markers of skin disease in systemic sclerosis

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3887555

Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3887555

Reproducible measurements to quantify cutaneous involvement in scleroderma

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3887555

The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3887555

Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3887555

Durometry for the assessment of skin disease in systemic sclerosis.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3887555

Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3887555

Skin score. A semiquantitative measure of cutaneous involvement that improves prediction of prognosis in systemic sclerosis

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3887555

Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3887555

Effect sizes for interpreting changes in health status.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3887555

The use of the Health Assessment Questionnaire (HAQ) to determine physical disability in systemic sclerosis

2 September 2018

1 reference

12 December 2020

Recombinant human anti–transforming growth factor β1 antibody therapy in systemic sclerosis: A multicenter, randomized, placebo-controlled phase I/II trial of CAT-192

1 reference

12 December 2020

Use of a durometer to assess skin hardness

1 reference

12 December 2020

Sensitivity to change of the health assessment questionnaire (HAQ) and other clinical and health status measures in rheumatoid arthritis: results of short-term clinical trials and observational studies versus long-term observational studies

1 reference

12 December 2020

Identifiers

DOI

10.1002/ART.23564

1 reference

Dimensions Publication ID

20 August 2017

0 references

1 reference

20 August 2017

PubMed publication ID

18438905

1 reference